Call for proposals: PhRMA Foundation seeks equity-focused research on digital health tools

Researchers must submit letters of intent by September 29 to compete for $500,000 in research grants

2023-07-17

(Press-News.org) The nonprofit PhRMA Foundation launched a new grant program to provide more than $1 million in funding for research on the use of digital health technologies (DHTs) in underrepresented populations in clinical trials to advance regulatory decision-making.

Based on applicants’ letters of intent, the Foundation will award up to eight $25,000 planning grants to support the development of detailed research proposals to compete for two $500,000 grants. Planning grant award recipients will also be offered a $5,000 promotional credit from Amazon Web Services (AWS) toward institutional use of AWS services. AWS will also provide scientific and technical subject-matter expertise to support the development of a proof of concept and/or refinement of existing cloud architecture on AWS.

“The COVID-19 pandemic accelerated the adoption of digital health tools such as sensors, apps, and wearables by allowing for the continuation of medical research while minimizing the risk of spreading disease,” PhRMA Foundation President Amy M. Miller, PhD, said. “These tools hold incredible promise for advancing research, but we must ensure that we are thoughtfully designing and implementing them to promote health equity and not exacerbating existing disparities in the health care ecosystem.”

The PhRMA Foundation seeks to fund research aimed at answering critical questions regarding the use of DHTs for regulatory decision-making for diverse populations. Research funded by this program could be directed toward the generation of evidence to support the verification, validation, and/or qualification of DHTs to measure and/or capture data across diverse populations. Funds could also be used to examine the use of DHTs in clinical trial recruitment, retention, and participation, especially for populations underrepresented in research.

Strong research proposals will:

Clearly address an unmet need related to diversity/equity in medical research   Include collaboration with community and/or patient groups   Include collaboration with pharmaceutical, device, or technology companies Demonstrate feasibility through preliminary data or provide details on how data will be gathered/accessed for the study   Explain how study outputs will impact regulatory decision-making to advance the use of DHTs in clinical research   Eligible applicants (U.S. and non-U.S. citizens) must be employed full time at an accredited U.S. university or research institution. Letters of intent are due by September 29, 2023, at 12:00 p.m. (noon) EDT. Visit the PhRMA Foundation website to learn more: https://bit.ly/PhF_DHTs

###

The PhRMA Foundation fosters biopharmaceutical innovation and value-driven health care by investing in the frontiers of research. The Foundation catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships in the fields of drug delivery, drug discovery, translational medicine, and value assessment and health outcomes research. Since its founding in 1965, the Foundation has awarded more than $110 million to over 2,700 researchers from diverse backgrounds at more than 300 institutions.

END

ELSE PRESS RELEASES FROM THIS DATE:

In determining what’s true, Americans consider the intentions of the information source

2023-07-17

Chestnut Hill, Mass. (7/17/2023) – Putting truth to the test in the “post-truth era”, Boston College psychologists conducted experiments that show when Americans decide whether a claim of fact should qualify as true or false, they consider the intentions of the information source, the team reported recently in Nature’s Scientific Reports. That confidence is based on what individuals think the source is trying to do – in this case either informing or deceiving their audience. “Even when people know precisely how accurate or inaccurate a claim of fact is, whether they consider that claim to be true or false hinges on the intentions ...

Broad-scope plant science journal publishes focus issue on critical biosecurity gap

2023-07-17

The vast scale of global trade presents a constant threat of introducing new plant diseases, which is challenging to the United States system of biosecurity. Plant health professionals often must respond quickly to a newly introduced or emerging plant disease outbreak even before a well-validated diagnostic test is available. Additionally, thousands of plant pathogens that already exist have been routinely diagnosed with assays that were not fully or consistently validated, which can lead to inaccurate diagnoses, delays in proper disease management, and significant consequences for growers and the public. Growing awareness of this gap in coordination and resources for plant disease ...

Political apathy spreads from parents to adolescent children

2023-07-17

Political apathy is growing in democracies around the world. Political apathy, also known as political alienation, describes feelings of separation and disaffection, a sense of powerlessness and an indifference to politics and political institutions. A hallmark of political alienation is a refusal to vote or participate in political activities. Adolescents and young adults are no exception to these trends. In many countries in Europe and North America, the youngest voters have the lowest participation rates. Why are new voters so apathetic about politics? Many factors are ...

Ambitious global $1 billion per year ‘mission science’ model needed to win on sustainable development in time, warns experts

2023-07-17

Ambitious global $1 billion per year ‘mission science’ model needed to win on sustainable development in time, warns experts From the climate emergency and global health to the energy transition and water security, new report argues the global science and science funding efforts must be fundamentally redesigned and scaled up to meet complex needs of humanity and the planet. July 17, 2023, NEW YORK – The current sustainability science model requires a fundamental redesign to keep up with the pace and complexity of the challenges facing the planet, argues the high-level ...

New study uncovers taxonomic breakthrough in the common ophiuroid Ophiothrix angulata (Echinodermata: Ophiuroidea)

2023-07-17

Ophiothrix angulata, a widely recognized and prevalent ophiuroid species in the Western Atlantic, has long been the subject of taxonomic debate due to its remarkable morphological diversity. A new study just published in PeerJ Life & Environment has shed light on the species' taxonomy, revealing a significant scientific breakthrough. Led by a team of researchers from Universidad Nacional Autónoma de México, Universidad Católica del Maule and Florida Natural History Museum, the comprehensive study aimed to assess species delimitation ...

Sergio Amancio receives 2023 Yoshiaki Arata Award

2023-07-17

On the occasion of its annual general assembly in Singapore on 16 July 2023, the International Institute of Welding presented Sergio Amancio, from the Institute of Materials Science, Joining and Forming at Graz University of Technology (TU Graz), with this year’s Yoshiaki Arata Award in recognition of his scientific achievements. This award, consisting of a medal and a certificate, is considered one of the world’s most important awards for research in welding and additive manufacturing and usually goes to veteran researchers who are recognised for their life’s work. For ...

Current evidence identifies health risks of e-cigarette use; long-term research needed

2023-07-17

Statement Highlights: The number of people who use electronic nicotine delivery systems, typically referred to as e-cigarettes, has grown exponentially, especially among youth and young adults. E-cigarette use more than doubled from 2017 to 2019 among middle and high school students. Ingredients of e-cigarettes, including nicotine, flavoring agents, sweeteners and propylene glycol and vegetable glycerol, may each independently pose dangerous health risks. More clinical studies on the long-term impact of e-cigarettes on the heart, blood vessels and lungs are needed, and experts emphasize additional molecular and laboratory research ...

Developing new materials to accelerate the arrival of 'air taxis'

2023-07-17

In order for future mobility, such as urban air mobility (UAM), to become a reality, it must be fuel efficient and reduce carbon emissions, which requires the development of new materials with excellent physical properties and recyclability. Self-reinforced composites (SRCs) are inexpensive, lightweight, and have advantages in terms of disposal and recycling as the reinforcement and the base material are composed of the same material. For this reason, it is attracting attention as a next-generation composite material to replace carbon fiber-reinforced composites used in aircraft. Korea Institute of Science and Technology (KIST, President ...

New findings suggest historical infanticide in Europe likely more widespread than estimated

2023-07-17

‘Routine’ infanticide of newborns by married parents in early modern Europe was a much more widespread practice than previously thought, a new book posits. This fresh insight sits at the heart of a new book, Death Control in the West 1500–1800: Sex Ratios at Baptism in Italy, France and England, by Gregory Hanlon and contributors. The French-trained behavioural historian explains: “In most cases, infanticide was a crime leaving no aggrieved party seeking revenge if it was committed right away. It could be overlooked and forgotten with the passage of time.” Widespread infanticide Hanlon, who is Distinguished Research Professor at Dalhousie University in ...

Prescribing psychostimulants for people at risk of overdose

2023-07-17

Growing evidence supports prescribing psychostimulant medications to help reduce use of illegal stimulants such as methamphetamine, authors write in a CMAJ (Canadian Medical Association Journal) commentaryhttps://www.cmaj.ca/lookup/doi/10.1503/cmaj.230266. Illegal stimulant use is rising, judging by the presence of these drugs in at least half of all opioid deaths in Canada in 2022. Following evidence from clinical trials in Australia, Europe and the United States, physicians and nurse practitioners in Canada and other countries are increasingly prescribing psychostimulants as harm reduction for stimulant use disorder. "This emerging ...

Call for proposals: PhRMA Foundation seeks equity-focused research on digital health tools

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: